CN113679399B

CN113679399B - A trigeminal ganglion compression device

Info

Publication number: CN113679399B
Application number: CN202010409196.5A
Authority: CN
Inventors: 顾海军; 王兴娅; 王远强
Original assignee: Shanghai Yueling Medical Technology Co ltd
Current assignee: Shanghai Yueling Medical Technology Co ltd
Priority date: 2020-05-14
Filing date: 2020-05-14
Publication date: 2025-08-22
Anticipated expiration: 2040-05-14
Also published as: CN113679399A

Abstract

The present invention provides a trigeminal ganglion compression device, comprising: a balloon, a support tube, a first electrode, a second electrode, a first wire, a second wire and a connector, wherein an injection cavity is provided on the connector, one end of the support tube is inserted into the balloon, the other end of the support tube is connected to the connector, and the support tube is connected to the injection cavity, the first electrode and the second electrode are both used to collect nerve signals, the first electrode is arranged at the proximal end of the balloon, one end of the first wire is connected to the first electrode, and the other end extends to the outside of the balloon, the second electrode is configured to fit on the patient's face, and the second wire is connected to the second electrode. The above-mentioned trigeminal ganglion compression device can achieve clinical effects of rapid and accurate treatment and improved prognosis, can improve the cure rate of the disease, and is conducive to the widespread promotion and application of trigeminal ganglion balloon compression technology.

Description

Trigeminal nerve semilunar node compression device

Technical Field

The invention relates to the field of medical equipment, in particular to a trigeminal nerve semilunar joint compression device.

Background

The action mechanism of the trigeminal balloon compression technology (PBC) is that the balloon is inflated at the trigeminal ganglion to compress the mechanically damaged nerve root and the trigeminal ganglion, so that the pain nerve signal of the trigeminal nerve area is weakened, and the treatment effect is further achieved. In general, main factors influencing the treatment effect in the trigeminal ganglion balloon compression operation include balloon filling shape and compression time, wherein the balloon shape is not easy to control, a doctor mainly judges whether the balloon filling reaches an ideal shape (such as pear shape) through images, the judgment of the balloon filling shape is greatly influenced by subjective factors of the doctor, the treatment effect cannot be quantitatively evaluated, the treatment effect difference between different doctors is larger, even the treatment effect between different patients treated by the same doctor is also larger, the cure rate of diseases is influenced, and the popularization and application of the trigeminal ganglion balloon compression technology are not facilitated.

Disclosure of Invention

The invention aims to provide the trigeminal nerve semilunar node compression device which can improve the disease cure rate and is beneficial to popularization and application of the trigeminal nerve semilunar node balloon compression technology.

To achieve the purpose, the invention adopts the following technical scheme:

The trigeminal nerve half moon pressing device comprises a balloon, a support tube, a first electrode, a second electrode, a first lead, a second lead and a connecting piece, wherein a liquid injection cavity is formed in the connecting piece, one end of the support tube is inserted into the balloon, the other end of the support tube is connected with the connecting piece, the support tube is communicated with the liquid injection cavity, the first electrode and the second electrode are both used for collecting nerve signals, the first electrode is arranged at the proximal end of the balloon, one end of the first lead is connected with the first electrode, the other end of the first lead extends to the outer side of the balloon, the second electrode is configured to be attached to the face of a patient, and the second lead is connected with the second electrode.

In one embodiment, the support tube is provided with a mounting portion, and the second electrode is detachably connected to the mounting portion.

In one embodiment, the second electrode is connected to the mounting portion in a clamping manner.

In one embodiment, the trigeminal semilunar node compression device further comprises a seal head, wherein the seal head is provided with an arc-shaped surface, and the seal head penetrates through the balloon and is fixedly connected with the support tube.

In one embodiment, the trigeminal semilunar joint pressing device further comprises a first metal retaining ring and a second metal retaining ring, wherein the first metal retaining ring is sleeved on the outer side of the distal end of the balloon, the first metal retaining ring fastens and fixes the distal end of the balloon on the supporting tube, the second metal retaining ring is sleeved on the outer side of the proximal end of the balloon, and the second metal retaining ring fastens and fixes the proximal end of the balloon on the supporting tube.

In one embodiment, the trigeminal semilunar node pressing device further comprises an injector, and the injector is connected with the connecting piece in a plugging mode.

In one embodiment, the injector is further provided with a threaded portion, and the connecting piece is provided with threads, and the threaded portion is in threaded connection with the connecting piece.

In one embodiment, the support tube is a single lumen tube or a multi-lumen tube.

In one of the embodiments, the support tube has two lumens, wherein,

The two cavities respectively form a fluid channel and a guide wire channel, the connecting piece is provided with a guide wire through hole, the fluid channel is respectively communicated with the balloon and the liquid injection cavity, the guide wire channel is respectively communicated with the balloon and the guide wire through hole, or,

The two cavities respectively form a fluid channel and a wire channel, the connecting piece is provided with a lead channel, the fluid channel is respectively communicated with the saccule and the liquid injection cavity, and the wire channel is communicated with the lead channel.

In one embodiment, the support tube is provided with at least three cavities, wherein at least three cavities respectively form a fluid channel, a wire channel and a wire guide channel, the connecting piece is provided with a wire guide channel and a wire guide through hole, the fluid channel is respectively communicated with the balloon and the liquid injection cavity, the wire guide channel is communicated with the wire guide channel, and the wire guide channel is respectively communicated with the balloon and the wire guide through hole.

The first electrode and the second electrode are respectively connected with the external electrophysiological nerve signal monitoring device through the first lead and the second lead when the trigeminal nerve half-moon pressing device is used, and the sizes of the trigeminal nerve pain nerve signals before and during operation of a patient can be monitored through the electrophysiological nerve signal monitoring device, so that whether treatment reaches an expected pain disappearance effect can be judged through the difference of the nerve signals, the treatment effect can be quantitatively evaluated, and the defect that the treatment effect is uneven due to the fact that no quantitative parameter is used for evaluating the treatment standard clinically at present can be effectively overcome. Clinical experiments prove that the trigeminal nerve half-moon pressing device can achieve the clinical effects of accurate treatment, rapid treatment, prognosis improvement and complication reduction by monitoring the difference value of the nerve signals before and after treatment, can improve the cure rate of diseases, and is favorable for the wide popularization and application of the trigeminal nerve half-moon balloon pressing technology.

Drawings

Fig. 1 is a schematic structural view of a trigeminal semilunar joint compression device according to the first embodiment;

FIG. 2 is a schematic structural view of a balloon in one embodiment;

FIG. 3 is a schematic view of the structure of a balloon in another embodiment;

FIG. 4 is a schematic structural view of a seal head in one embodiment;

FIG. 5 is a schematic view of the structure of a syringe in one embodiment;

fig. 6 is a schematic structural view of a trigeminal semilunar joint compression device according to the second embodiment;

FIG. 7 is a cross-sectional view of the support tube in the trigeminal semilunar joint compression device shown in FIG. 6;

fig. 8 is a schematic structural view of a trigeminal semilunar joint compression device according to the third embodiment;

FIG. 9 is a structural cross-sectional view of a support tube in the trigeminal semilunar joint compression device shown in FIG. 8;

fig. 10 is a schematic structural view of a trigeminal semilunar joint compression device according to the fourth embodiment;

Fig. 11 is a structural cross-sectional view of a support tube in the trigeminal ganglion compression device shown in fig. 10.

Reference numerals illustrate:

10-balloon, 14-first electrode, 15-second electrode, 16-first lead, 17-second lead, 18-connector, 19-closure, 20-first metal clasp, 21-second metal clasp, 22-syringe, 30-support tube, 31-fluid channel, 32-lead channel, 33-wire channel, 34-inner support tube, 35-outer support tube, 36-through hole, 37-mount;

181-liquid injection cavity, 182-lead channel, 183-guide wire through hole, 191-arc surface, 221-screw thread part.

Detailed Description

The following description of the embodiments of the present invention will be made clearly and completely with reference to the accompanying drawings, in which it is apparent that the embodiments described are only some embodiments of the present invention, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.

In the description of the present invention, it should be understood that the terms "upper", "lower", "front", "rear", "left", "right", "vertical", "horizontal", "top", "bottom", "inner", "outer", etc. indicate orientations or positional relationships based on the orientations or positional relationships shown in the drawings, are merely for convenience in describing the present invention and simplifying the description, and do not indicate or imply that the devices or elements referred to must have a specific orientation, be configured and operated in a specific orientation, and thus should not be construed as limiting the present invention.

Example 1

Referring to fig. 1 to 5, the trigeminal semilunar node compression device according to an embodiment includes a balloon 10, a support tube 30, a first electrode 14, a second electrode 15, a first lead 16, a second lead 17 and a connecting member 18, wherein a liquid injection cavity 181 is formed on the connecting member 18, one end of the support tube 30 is inserted into the balloon 10, the other end of the support tube 30 is connected with the connecting member 18, the support tube 30 is communicated with the liquid injection cavity 181, the first electrode 14 and the second electrode 15 are both used for acquiring nerve signals, the first electrode 14 is disposed at the proximal end of the balloon 10, one end of the first lead 16 is connected with the first electrode 14, the other end extends to the outer side of the balloon 10, the second electrode 15 is configured to be attached to the face of a patient, and the second lead 17 is connected with the second electrode 15.

In one embodiment, the first electrode 14 and the second electrode 15 may be, but are not limited to, sheet-like or tubular, the first electrode 14 being fixedly secured to the support tube 30 on the proximal side of the balloon 10, the second electrode 15 being configured to be capable of fitting against the patient's face in use. Specifically, the distal end and the proximal end of the balloon 10 are fixed to the inner support tube 30 by bonding, high-strength fiber winding, welding or heat sealing, the first wire 16 extends to the outside of the balloon 10 and is connected to an external electrophysiological nerve signal monitoring device, and the second wire 17 may be directly connected to the external electrophysiological nerve signal monitoring device. Further, in one embodiment, the first lead 16 and the second lead 17 are connected to the electrophysiological nerve signal monitoring device, respectively, to form a closed loop. Specifically, in this embodiment, the support tube 30 is a single-lumen tube body, the inner cavity of the support tube 30 is used as a fluid channel and a guide wire channel at the same time, and a portion of the support tube 30 located inside the balloon 10 is provided with a plurality of circular, oval or other through holes 36, and the contrast agent is injected into the balloon 10 through the through holes 36. Further, the supporting tube 30 is made of a medical polymer material, which may be, but not limited to, PVC, PU, PA, PE, PP or other medical polymer materials.

When the trigeminal semilunar joint pressing device is used, the first electrode 14 and the second electrode 15 are connected with an external electrophysiological nerve signal monitoring device through the first lead 16 and the second lead 17 respectively, and the sizes of trigeminal nerve pain nerve signals before and during operation of a patient can be monitored through the electrophysiological nerve signal monitoring device, so that whether treatment achieves an expected pain disappearance effect or not can be judged through the difference of nerve signals, the treatment effect can be quantitatively evaluated, and the defect that the treatment effect is uneven due to the fact that no quantitative parameter is used for evaluating treatment standards clinically at present can be effectively overcome. Clinical experiments prove that the trigeminal nerve half-moon pressing device can achieve the clinical effects of accurate treatment, rapid treatment, prognosis improvement and complication reduction by monitoring the difference value of the nerve signals before and after treatment, can improve the cure rate of diseases, and is favorable for the wide popularization and application of the trigeminal nerve half-moon balloon pressing technology.

In one embodiment, the trigeminal semilunar stent compression device also encloses a head 19, the head 19 having an arcuate surface 191, the head 19 being fixedly connected to the support tube 30 through the balloon 10. Specifically, the arc surface 191 on the seal head 19 can reduce resistance in the pushing process of the trigeminal semilunar node pressing device, ensure smooth pushing, and contribute to improving the operation efficiency. The sealing head 19 can be made of metal such as stainless steel or medical polymer material such as PVC. The closure head 19 is partially inserted into the support tube 30 and fixedly connected to the support tube 30 by an adhesive, welding or heat sealing process.

In one embodiment, the trigeminal semilunar joint compression device further comprises a first metal clasp 20 and a second metal clasp 21, wherein the first metal clasp 20 is sleeved outside the distal end of the balloon 10, the first metal clasp 20 fastens and fixes the distal end of the balloon 10 on the support tube 30, the second metal clasp 21 is sleeved outside the proximal end of the balloon 10, and the second metal clasp 21 fastens and fixes the proximal end of the balloon 10 on the support tube 30.

Specifically, the first metal clasp 20 and the second metal clasp 21 are both in a metal tubular shape or a metal wire shape, and the first metal clasp 20 and the second metal clasp 21 may be made of stainless steel, tungsten, titanium, platinum, gold, silver, or an alloy, etc., and the first metal clasp 20 and the second metal clasp 21 are used to provide X-ray developability during the operation, and clearly indicate the position of the balloon 10 in the human tissue. In this embodiment, the distal end of the balloon 10 is further fastened and fixed on the support tube 30 by the first metal retaining ring 20, and meanwhile, the proximal end of the balloon 10 is fastened and fixed on the support tube 30 by the second metal retaining ring 21, so that the connection between the balloon 10 and the support tube 30 can be ensured to be stable and reliable.

In one embodiment, the trigeminal semilunar joint compression device further includes a syringe 22, the syringe 22 being in plug connection with the connector 18. Specifically, the injector 22 is used for injecting a contrast agent into the injection cavity 181 of the connector 18, and the contrast agent enters the injection cavity 181 and then enters the balloon 10 through the support tube 30, so that the balloon 10 is inflated to compress the trigeminal nerve, and the therapeutic purpose is achieved.

In one embodiment, the injector 22 is further provided with a threaded portion 221, the connection 18 being provided with threads, the threaded portion 221 being threadedly connected to the connection 18. In this embodiment, the injector 22 is screwed with the connecting member 18, so that the tightness of the trigeminal ganglion compression device can be improved. Specifically, in this embodiment, the threaded portion 221 is provided with an internal thread, and the connecting member 18 is provided with an external thread, however, in other embodiments, the threaded portion 221 may be provided with an external thread, and the connecting member 18 may be provided with an internal thread, which may achieve the same technical effect, and this embodiment is not limited specifically.

In one embodiment, the balloon 10 is a balloon-type balloon (as shown in fig. 2) or a capsule-type balloon, and the balloon 10 is made of an elastic material, which may be specifically a compliant or semi-compliant material. In another embodiment, as shown in fig. 3, the balloon 10 is a pear-shaped balloon made of pear-shaped water jacket, and correspondingly, the balloon 10 may be made of natural latex, polyurethane, thermoplastic elastomer polymer material, silica gel or rubber, etc. In particular, balloon 10 may change shape with human tissue after expansion during surgery, be pear-shaped or otherwise shaped. In practical applications, the balloon 10 may be any balloon with any shape as required, and the above embodiment is not particularly limited.

In one embodiment, the support tube 30 is provided with a mounting portion 37, and the second electrode 15 is detachably connected to the mounting portion 37. Specifically, the second electrode 15 is detachably connected with the mounting portion 37, when the trigeminal nerve half moon pressing device works, the second electrode 15 is taken down from the mounting portion 37 and attached to the face of a patient, after the operation is finished, the second electrode 15 is mounted on the mounting portion 37, the second electrode 15 can be prevented from being independently placed and lost, and the device is convenient to use. Further, in one embodiment, the second electrode 15 is connected to the mounting portion 37 in a clamping manner, specifically, the mounting portion 37 may be a groove formed on the outer surface of the support tube 30, or may be a protrusion provided on the outer surface of the support tube 30 and having a clamping groove, and the structure of the mounting portion 37 may be arbitrarily set according to actual needs, which is not limited in this embodiment.

Example two

In the first embodiment, the support tube 30 of the trigeminal ganglion compression device is a single-lumen tube, and in other embodiments, the support tube 30 may be a multi-lumen tube, and in this embodiment, the support tube 30 is a dual-lumen tube. Referring to fig. 6 to 7, the support tube 30 has two cavities, which respectively form a fluid channel 31 and a guide wire channel 33, the connecting piece 18 is provided with a guide wire through hole 183, the fluid channel 31 is respectively communicated with the balloon 10 and the liquid injection cavity 181, and the guide wire channel 33 is respectively communicated with the balloon 10 and the guide wire through hole 183. Specifically, the support tube 30 includes an inner support tube 34 and an outer support tube 35, the inner support tube 34 is sleeved on the inner side of the outer support tube 35, the inner support tube 34 and the outer support tube 35 are sleeved to form a double-cavity structure, wherein an inner cavity of the inner support tube 34 is used as a guide wire channel, a gap between the inner support tube 34 and the outer support tube 35 forms another cavity, and as a fluid channel, a contrast agent enters the bag body 10 through the gap between the inner support tube 34 and the outer support tube 35, so that a through hole is not required to be formed on the inner support tube 21 and the outer support tube 35. In this embodiment, the support tube 30 is sleeved with the inner support tube 34 and the outer support tube 35 to form a dual-cavity structure, in other embodiments, the support tube 30 may also directly adopt a dual-cavity tube, one cavity of the dual-cavity tube is used as the fluid channel 31, the other cavity is used as the guide wire channel 33, and in practical application, the specific structure of the support tube 30 may be selected according to actual needs, and this embodiment is not limited specifically.

Further, in this embodiment, one end of the inner support tube 34 is connected to the distal end of the balloon 10, the other end of the inner support tube 34 extends to the outside of the balloon 10 and then is inserted into the connector 18 to be communicated with the liquid injection cavity 181, the outer support tube 35 is sleeved outside the inner support tube 34, one end of the outer support tube 35 is connected to the proximal end of the balloon 10, the other end of the outer support tube 35 is connected to the connector 18, the first electrode 14 is clamped and fixed on the inner support tube 34 on the proximal end side of the balloon 10, and the distal end and the proximal end of the balloon 10 are fixed on the outer wall of the inner support tube 34 through bonding, high-strength fiber winding, welding or heat sealing processes. The first lead 16 extends outside the balloon 10 and is connected to an external electrophysiological nerve signal monitoring device. The first metal clasp 20 is sleeved outside the distal end of the balloon 10, the first metal clasp 20 fastens and fixes the distal end of the balloon 10 on the inner support tube 34, the second metal clasp 21 is sleeved outside the proximal end of the balloon 10, and the second metal clasp 21 fastens and fixes the proximal end of the balloon 10 on the outer support tube 35. The difference between the trigeminal semilunar node pressing device of the present embodiment and the trigeminal semilunar node pressing device of the first embodiment is that the supporting tube 30 has different numbers of cavities, and the structures and the compositions of the components such as the sealing head 19 and the injector 22 in the device are the same, and are not described herein.

Example III

Referring to fig. 8 to 9, in the present embodiment, the support tube 30 of the trigeminal nerve half moon pressing device is a dual-cavity tube, two cavities of the support tube 30 respectively form a fluid channel 31 and a wire channel 32, the connecting piece 18 is provided with a wire channel 182, the fluid channel 31 is respectively communicated with the balloon 10 and the infusion cavity 181, and the wire channel 32 is communicated with the wire channel 182.

Specifically, the support tube 30 includes an inner support tube 34 and an outer support tube 35, the inner support tube 34 is sleeved on the inner side of the outer support tube 35, the inner support tube 34 and the outer support tube 35 are sleeved to form a dual-cavity structure, wherein an inner cavity of the inner support tube 34 serves as a fluid channel 31 and also serves as a guide wire channel, a gap between the inner support tube 34 and the outer support tube 35 forms another cavity, the gap serves as a guide wire channel 32, a through hole 36 is formed in the inner support tube 34, and a contrast agent enters the capsule 10 through the fluid channel 31 of the inner support tube 34 and then passes through the through hole 36. In this embodiment, the support tube 30 is sleeved with the inner support tube 34 and the outer support tube 35 to form a dual-cavity structure, in other embodiments, the support tube 30 may also directly adopt a dual-cavity tube, one cavity of the dual-cavity tube is used as the fluid channel 31, the other cavity is used as the wire channel 32, and the specific structure of the support tube 30 can be selected according to actual needs in practical application, which is not limited in this embodiment.

In this embodiment, the first electrode 14 is fastened and fixed on the inner support tube 34 at the proximal end of the balloon 10, one end of the first wire 16 is connected to the first electrode 14, and the other end of the first wire passes through the wire channel 32 and then extends to the outer side of the connecting piece 18 through the wire channel 182, so as to be connected to an external electrophysiological nerve signal monitoring device. In this embodiment, the supporting tube 30 has the wire channel 32, and the connecting piece 18 is provided with the wire channel 182, and the first wire 16 passes through the wire channel 182 after passing through the wire channel 32 and extends to the outer side of the connecting piece 18, so that the first wire 16 can be effectively prevented from being wound or damaged, which is beneficial to protecting the first wire 16 and is convenient to use. The difference between the trigeminal semilunar node pressing device of the present embodiment and the trigeminal semilunar node pressing device of the second embodiment is that the supporting tube 30 has a different flow channel function of the cavity, and other structures, such as the structure and the composition of the components of the sealing head 19 and the injector 22, are the same as those of the first embodiment, and will not be described herein.

Example IV

Referring to fig. 10 to 11, in the present embodiment, the support tube 30 has three cavities, which respectively form a fluid channel 31, a wire channel 32 and a wire channel 33, the connecting piece 18 is provided with a wire channel 182 and a wire through hole 183, the fluid channel 31 is respectively communicated with the balloon 10 and the liquid injection cavity 181, the wire channel 32 is communicated with the wire channel 182, and the wire channel 33 is respectively communicated with the balloon 10 and the wire through hole 183. Specifically, the contrast medium is injected into the balloon 10 through the fluid channel 31, the first lead 16 passes through the lead channel 182 after passing through the lead channel 32 and extends to the outer side of the connecting piece 18, the lead channel 32 is used for the lead to pass through, and the fluid channel 31, the lead channel 32 and the lead channel 33 are separately and independently arranged, so that the use can be further facilitated. The trigeminal semilunar node pressing device of this embodiment is different from the trigeminal semilunar node pressing device of the first, second and third embodiments in that the number of cavities of the supporting tube 30 is different, and the structures and compositions of the components such as the end socket 19 and the injector 22 in the device are the same, and are not described here again.

The following specifically describes the use process of the trigeminal semilunar node compression device according to the third embodiment. Specifically, specific clinical procedures for performing surgery using the trigeminal ganglion compression device in example three were as follows:

Firstly, taking a patient in a supine position after general anesthesia, wrapping a shoulder pad to a proper height to ensure slight extension of a neck, then establishing a channel from a position which is about 2.5cm beside an affected side opening angle by means of X-ray image positioning in an X-ray environment, inserting the balloon 10, attaching a second electrode 15 on the face of the patient after the balloon 10 enters a half-moon of a trigeminal nerve of a Meckle's cavity to be positioned, measuring nerve signals before treatment by using an electrophysiological nerve signal monitoring device, then injecting a diluted contrast agent into an inner supporting tube 34 through an injection cavity 181 of a connecting piece 18 to enable the balloon 10 and the filling to expand, at the moment, ensuring that the injected diluted contrast agent just fills up a Meckle's cavity, monitoring the filling shape of the balloon 10 through the X-ray image, monitoring the nerve signals in the treatment process through the electrophysiological nerve signal monitoring device, continuously adjusting the shape and position of the balloon 10 and the expanded trigeminal nerve for 3-7 minutes, and pressing the balloon 10 and the expanded trigeminal nerve for 3-7 minutes when the optimal treatment signal value is reached, namely the contrast agent is successfully extracted when the operation difference value of the nerve signals is reached.

The trigeminal nerve half-moon compression device can be connected with the electrophysiological nerve signal monitoring device to monitor the sizes of trigeminal nerve pain nerve signals before and during operation of a patient, so that whether treatment achieves an expected pain disappearance effect can be judged through the difference of nerve signals, the treatment effect can be quantitatively evaluated, the defect that the treatment effect is uneven caused by evaluating treatment standards without quantitative parameters clinically is overcome, the clinical effects of accurate treatment, rapid treatment, improvement of prognosis and reduction of complications can be achieved, the disease cure rate can be effectively improved, and the trigeminal nerve half-moon balloon compression technology is widely popularized and applied.

The technical features of the above-described embodiments may be arbitrarily combined, and all possible combinations of the technical features in the above-described embodiments are not described for brevity of description, however, as long as there is no contradiction between the combinations of the technical features, they should be considered as the scope of the description.

The above examples illustrate only a few embodiments of the invention, which are described in detail and are not to be construed as limiting the scope of the invention. It should be noted that it will be apparent to those skilled in the art that several variations and modifications can be made without departing from the spirit of the invention, which are all within the scope of the invention. Accordingly, the scope of protection of the present invention is to be determined by the appended claims.

Claims

1. The trigeminal ganglion compression device is characterized by comprising a balloon (10), a support tube (30), a first electrode (14), a second electrode (15), a first lead (16), a second lead (17) and a connecting piece (18), wherein a liquid injection cavity (181) is formed in the connecting piece (18), one end of the support tube (30) is inserted into the balloon (10), the other end of the support tube (30) is connected with the connecting piece (18), the support tube (30) is communicated with the liquid injection cavity (181), the first electrode (14) and the second electrode (15) are used for collecting nerve signals, the first electrode (14) is arranged at the proximal end of the balloon (10), one end of the first lead (16) is connected with the first electrode (14), the other end of the first lead (16) extends to the outer side of the balloon (10), the second electrode (15) is configured to be attached to the face of a patient, and the second lead (17) is connected with the second electrode (15);

When the trigeminal semilunar joint pressing device is used, the first electrode (14) and the second electrode (15) are respectively connected with an external electrophysiological nerve signal monitoring device through the first lead (16) and the second lead (17), the size of trigeminal nerve pain nerve signals before and during operation of a patient can be monitored through the electrophysiological nerve signal monitoring device, and whether the treatment achieves the expected pain disappearance effect or not is judged through the difference of nerve signals.

2. The trigeminal lunar ganglion compression device according to claim 1, wherein the support tube (30) is provided with a mounting portion (37), and the second electrode (15) is detachably connected to the mounting portion (37).

3. The trigeminal lunar ganglion compression device according to claim 2, wherein the second electrode (15) is snap-connected to the mounting portion (37).

4. The trigeminal semilunar node compression device according to claim 1, further comprising a head (19), the head (19) having an arcuate surface (1921), the head (19) being fixedly connected to the support tube (30) through the balloon (10).

5. The trigeminal lunar ganglion compression device according to claim 1, further comprising a first metal clasp (20) and a second metal clasp (21), wherein the first metal clasp (20) is sleeved outside the distal end of the balloon (10), and the first metal clasp (20) fastens the distal end of the balloon (10) to the support tube (30), the second metal clasp (21) is sleeved outside the proximal end of the balloon (10), and the second metal clasp (21) fastens the proximal end of the balloon (10) to the support tube (30).

6. The trigeminal lunar ganglion compression device according to claim 1, further comprising a syringe (22), the syringe (22) being in plug-in connection with the connector (18).

7. The trigeminal lunar ganglion compression device according to claim 6, wherein the syringe (22) is further provided with a threaded portion (221), the connecting member (18) is provided with threads, and the threaded portion (221) is in threaded connection with the connecting member (18).

8. The trigeminal semilunar joint compression device according to any one of claims 1 to 7, wherein the support tube (30) is a single lumen tube or a multi-lumen tube.

9. The trigeminal lunar ganglion compression device according to claim 8, wherein the support tube (30) has two lumens, wherein,

The two cavities respectively form a fluid channel (31) and a guide wire channel (33), the connecting piece (18) is provided with a guide wire through hole (183), the fluid channel (31) is respectively communicated with the balloon (10) and the liquid injection cavity (181), the guide wire channel (33) is respectively communicated with the balloon (10) and the guide wire through hole (183), or,

The two cavities respectively form a fluid channel (31) and a wire channel (32), a wire channel (182) is formed in the connecting piece (18), the fluid channel (31) is respectively communicated with the balloon (10) and the liquid injection cavity (181), and the wire channel (32) is communicated with the wire channel (182).

10. The trigeminal lunar ganglion compression device according to claim 8, wherein the support tube (30) has at least three cavities, wherein the at least three cavities form a fluid channel (31), a wire channel (32) and a wire channel (33), the connecting piece (18) is provided with a wire channel (182) and a wire through hole (183), the fluid channel (31) is respectively communicated with the balloon (10) and the infusion cavity (181), the wire channel (32) is communicated with the wire channel (182), and the wire channel (33) is respectively communicated with the balloon (10) and the wire through hole (183).